• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤中不饱和与饱和硫酸化神经酰胺种类的比值与肝内胆管癌的无病生存相关。

Tumor ratio of unsaturated to saturated sulfatide species is associated with disease-free survival in intrahepatic cholangiocarcinoma.

机构信息

Maastricht Multimodal Molecular Imaging Institute (M4I), Maastricht University, Universiteitssingel 50, 6229 ER, Maastricht, The Netherlands.

Department of Surgery, Maastricht University Medical Center and NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University, PO BOX 616, 6200 MD, Maastricht, The Netherlands.

出版信息

Cell Oncol (Dordr). 2023 Jun;46(3):629-642. doi: 10.1007/s13402-022-00766-6. Epub 2023 Jan 11.

DOI:10.1007/s13402-022-00766-6
PMID:36630049
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10205872/
Abstract

PURPOSE

Cholangiocarcinoma (CCA) is a malignancy arising from the bile duct epithelium and has a poor outcome. Sulfatides are lipid components of lipid rafts, and are implicated in several cancer types. In the liver, sulfatides are specifically present in the bile ducts. Here, sulfatide abundance and composition were analyzed using mass spectrometry imaging in intrahepatic CCA (iCCA) tumor tissue, and correlated with tumor biology and clinical outcomes.

METHODS

Sulfatides were analyzed in iCCA (n = 17), hepatocellular carcinoma (HCC, n = 10) and colorectal liver metastasis (CRLM, n = 10) tumor samples, as well as tumor-distal samples (control, n = 16) using mass spectrometry imaging. Levels of sulfatides as well as the relative amount in structural classes were compared between groups, and were correlated with clinical outcomes for iCCA patients.

RESULTS

Sulfatide localization was limited to the respective tumor areas and the bile ducts. Sulfatide abundance was similar in iCCA and control tissue, while intensities were notably higher in CRLM in comparison with control (18-fold, P < 0.05) and HCC tissue (47-fold, P < 0.001). Considerable variation in sulfatide abundance was observed in iCCA tumors. A high ratio of unsaturated to saturated sulfatides was associated with reduced disease-free survival (10 vs. 20 months) in iCCA. The sulfatide pattern in HCC deviated from the other groups, with a higher relative abundance of odd- versus even-chain sulfatides.

CONCLUSION

Sulfatides were found in tumor tissue of patients with iCCA, with sulfatide abundance per pixel being similar to bile ducts. In this explorative study, sulfatide abundance was not related to overall survival of iCCA patients. A high ratio of unsaturated to saturated sulfatides was associated with earlier tumor recurrence in patients with iCCA.

摘要

目的

胆管癌(CCA)是一种起源于胆管上皮的恶性肿瘤,预后不良。硫酸酯是脂筏的脂质成分,与多种癌症类型有关。在肝脏中,硫酸酯特异性存在于胆管中。在这里,使用质谱成像分析了肝内 CCA(iCCA)肿瘤组织中的硫酸酯丰度和组成,并将其与肿瘤生物学和临床结果相关联。

方法

使用质谱成像分析了 iCCA(n=17)、肝细胞癌(HCC,n=10)和结直肠癌肝转移(CRLM,n=10)肿瘤样本以及肿瘤远端样本(对照,n=16)中的硫酸酯。比较了各组之间硫酸酯的水平及其结构类别中的相对含量,并与 iCCA 患者的临床结果相关联。

结果

硫酸酯的定位仅限于各自的肿瘤区域和胆管。iCCA 和对照组织中的硫酸酯丰度相似,而 CRLM 与对照组织(18 倍,P<0.05)和 HCC 组织(47 倍,P<0.001)相比,强度明显更高。在 iCCA 肿瘤中观察到硫酸酯丰度的显著变化。不饱和硫酸酯与饱和硫酸酯的高比值与 iCCA 患者无疾病生存时间缩短(10 个月 vs. 20 个月)相关。HCC 的硫酸酯模式与其他组不同,奇数链硫酸酯的相对丰度较高。

结论

在 iCCA 患者的肿瘤组织中发现了硫酸酯,每个像素的硫酸酯丰度与胆管相似。在这项探索性研究中,硫酸酯丰度与 iCCA 患者的总生存无关。不饱和硫酸酯与饱和硫酸酯的高比值与 iCCA 患者的肿瘤早期复发相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1309/10205872/68ad735cbba5/13402_2022_766_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1309/10205872/c319e615ebe6/13402_2022_766_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1309/10205872/69042acc6da7/13402_2022_766_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1309/10205872/9beb5c95c652/13402_2022_766_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1309/10205872/a7914cc7c3a8/13402_2022_766_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1309/10205872/68ad735cbba5/13402_2022_766_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1309/10205872/c319e615ebe6/13402_2022_766_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1309/10205872/69042acc6da7/13402_2022_766_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1309/10205872/9beb5c95c652/13402_2022_766_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1309/10205872/a7914cc7c3a8/13402_2022_766_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1309/10205872/68ad735cbba5/13402_2022_766_Fig5_HTML.jpg

相似文献

1
Tumor ratio of unsaturated to saturated sulfatide species is associated with disease-free survival in intrahepatic cholangiocarcinoma.肿瘤中不饱和与饱和硫酸化神经酰胺种类的比值与肝内胆管癌的无病生存相关。
Cell Oncol (Dordr). 2023 Jun;46(3):629-642. doi: 10.1007/s13402-022-00766-6. Epub 2023 Jan 11.
2
Comparison of Clinical Features and Outcomes Between Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma in the United States.美国肝内胆管细胞癌与肝细胞癌的临床特征和结局比较。
Hepatology. 2021 Nov;74(5):2622-2632. doi: 10.1002/hep.32007. Epub 2021 Sep 25.
3
Revealing the role of necroptosis microenvironment: FCGBP + tumor-associated macrophages drive primary liver cancer differentiation towards cHCC-CCA or iCCA.揭示坏死性凋亡微环境的作用:FCGBP+肿瘤相关巨噬细胞驱动原发性肝癌向胆管细胞型肝细胞癌或肝内胆管癌分化。
Apoptosis. 2024 Apr;29(3-4):460-481. doi: 10.1007/s10495-023-01908-3. Epub 2023 Nov 28.
4
Component with abundant immune-related cells in combined hepatocellular cholangiocarcinoma identified by cluster analysis.通过聚类分析鉴定出富含免疫相关细胞的混合型肝细胞胆管细胞癌。
Cancer Sci. 2022 May;113(5):1564-1574. doi: 10.1111/cas.15313. Epub 2022 Mar 17.
5
Comparing the clinicopathological characteristics of combined hepatocellular-cholangiocarcinoma with those of other primary liver cancers by use of the updated World Health Organization classification.利用世界卫生组织更新后的分类标准,比较肝细胞-胆管细胞癌与其他原发性肝癌的临床病理特征。
Histopathology. 2021 Oct;79(4):556-572. doi: 10.1111/his.14384. Epub 2021 Jun 23.
6
Bile duct adenoma may be a precursor lesion of small duct type intrahepatic cholangiocarcinoma.胆管腺瘤可能是小胆管型肝内胆管癌的前驱病变。
Histopathology. 2021 Jan;78(2):310-320. doi: 10.1111/his.14222. Epub 2020 Sep 15.
7
Clinical Significance of Acylphosphatase 1 Expression in Combined HCC-iCCA, HCC, and iCCA.酰基磷酸酶1在合并肝细胞癌-肝内胆管癌、肝细胞癌和肝内胆管癌中的表达的临床意义
Dig Dis Sci. 2022 Aug;67(8):3817-3830. doi: 10.1007/s10620-021-07266-x. Epub 2021 Oct 9.
8
HNF-1β is a More Sensitive and Specific Marker Than C-Reactive Protein for Identifying Biliary Differentiation in Primary Hepatic Carcinomas.HNF-1β 是一种比 C 反应蛋白更敏感、更特异的标志物,可用于识别原发性肝癌的胆管分化。
Arch Pathol Lab Med. 2022 Jan 2;146(2):220-226. doi: 10.5858/arpa.2020-0725-OA.
9
Gut dysbiosis in Thai intrahepatic cholangiocarcinoma and hepatocellular carcinoma.泰国肝内胆管癌和肝细胞癌的肠道菌群失调。
Sci Rep. 2023 Jul 14;13(1):11406. doi: 10.1038/s41598-023-38307-2.
10
Is nestin a diagnostic marker for combined hepatocellular-cholangiocarcinoma?巢蛋白是否可作为肝细胞胆管细胞癌的诊断标志物?
Histopathology. 2022 Apr;80(5):859-868. doi: 10.1111/his.14622. Epub 2022 Mar 3.

引用本文的文献

1
GAL3ST1 Deficiency Reduces Epithelial-Mesenchymal Transition and Tumorigenic Capacity in a Cholangiocarcinoma Cell Line.GAL3ST1 缺乏可降低胆管癌细胞系中的上皮-间充质转化和致瘤能力。
Int J Mol Sci. 2024 Jul 2;25(13):7279. doi: 10.3390/ijms25137279.
2
Prognostic potential of lipid profiling in cancer patients: a systematic review of mass spectrometry-based studies.基于质谱的癌症患者脂质谱分析的预后潜力:系统综述。
Lipids Health Dis. 2024 May 25;23(1):154. doi: 10.1186/s12944-024-02121-0.
3
Reduced sulfatide content in deferoxamine-induced senescent HepG2 cells.

本文引用的文献

1
Histological Heterogeneity of Primary Liver Cancers: Clinical Relevance, Diagnostic Pitfalls and the Pathologist's Role.原发性肝癌的组织学异质性:临床相关性、诊断陷阱及病理学家的作用
Cancers (Basel). 2021 Jun 8;13(12):2871. doi: 10.3390/cancers13122871.
2
The prognostic value of galactosylceramide-sulfotransferase (Gal3ST1) in human renal cell carcinoma.半乳糖基神经酰胺-硫酸转移酶(Gal3ST1)在人肾细胞癌中的预后价值。
Sci Rep. 2021 May 25;11(1):10926. doi: 10.1038/s41598-021-90381-6.
3
2-Hydroxylation of Fatty Acids Represses Colorectal Tumorigenesis and Metastasis via the YAP Transcriptional Axis.
去铁胺诱导衰老 HepG2 细胞中硫酸脑苷脂含量降低。
Int J Biochem Cell Biol. 2023 Jun;159:106419. doi: 10.1016/j.biocel.2023.106419. Epub 2023 Apr 21.
脂肪酸的 2-羟化作用通过 YAP 转录轴抑制结直肠肿瘤发生和转移。
Cancer Res. 2021 Jan 15;81(2):289-302. doi: 10.1158/0008-5472.CAN-20-1517. Epub 2020 Nov 17.
4
Inhibition of glycosphingolipid biosynthesis reverts multidrug resistance by differentially modulating ABC transporters in chronic myeloid leukemias.抑制糖脂生物合成通过差异调节慢性髓性白血病中的 ABC 转运蛋白来逆转多药耐药性。
J Biol Chem. 2020 May 8;295(19):6457-6471. doi: 10.1074/jbc.RA120.013090. Epub 2020 Mar 30.
5
FA2H Exhibits Tumor Suppressive Roles on Breast Cancers via Cancer Stemness Control.FA2H通过控制癌症干性在乳腺癌中发挥肿瘤抑制作用。
Front Oncol. 2019 Oct 24;9:1089. doi: 10.3389/fonc.2019.01089. eCollection 2019.
6
A Hypoxia-Inducible HIF1-GAL3ST1-Sulfatide Axis Enhances ccRCC Immune Evasion via Increased Tumor Cell-Platelet Binding.缺氧诱导因子 HIF1-GAL3ST1-神经节苷脂轴通过增加肿瘤细胞-血小板结合增强 ccRCC 的免疫逃逸。
Mol Cancer Res. 2019 Nov;17(11):2306-2317. doi: 10.1158/1541-7786.MCR-19-0461. Epub 2019 Aug 19.
7
High FA2H and UGT8 transcript levels predict hydroxylated hexosylceramide accumulation in lung adenocarcinoma.FA2H 和 UGT8 转录本水平高可预测肺腺癌中羟化己糖神经酰胺的积累。
J Lipid Res. 2019 Oct;60(10):1776-1786. doi: 10.1194/jlr.M093955. Epub 2019 Aug 13.
8
Stearoyl-CoA Desaturase 1 as a Therapeutic Target for the Treatment of Cancer.硬脂酰辅酶A去饱和酶1作为癌症治疗的靶点
Cancers (Basel). 2019 Jul 5;11(7):948. doi: 10.3390/cancers11070948.
9
Pathogenesis, diagnosis and treatment of premalignant and malignant stages of cholangiocarcinoma in primary sclerosing cholangitis.原发性硬化性胆管炎中癌前和恶性阶段胆管癌的发病机制、诊断和治疗。
Liver Int. 2019 Dec;39(12):2230-2237. doi: 10.1111/liv.14180. Epub 2019 Oct 8.
10
Overexpression of HexCer and LacCer containing 2-hydroxylated fatty acids in cholangiocarcinoma and the association of the increase of LacCer (d18:1-h23:0) with shorter survival of the patients.在胆管癌中,含有 2-羟基脂肪酸的 HexCer 和 LacCer 过表达,并且 LacCer(d18:1-h23:0)的增加与患者的生存时间更短有关。
Glycoconj J. 2019 Apr;36(2):103-111. doi: 10.1007/s10719-019-09864-4. Epub 2019 Mar 19.